Analysis/NN
of/IN
myeloid-associated/JJ
genes/NNS
in/IN
human/JJ
hematopoietic/JJ
progenitor/NN
cells/NNS
./.

The/DT
distribution/NN
of/IN
myeloid/JJ
lineage-associated/JJ
cytokine/NN
receptors/NNS
and/CC
lysosomal/JJ
proteins/NNS
was/VBD
analyzed/VBN
in/IN
human/JJ
CD34+/JJ
cord/NN
blood/NN
cell/NN
(/(
CB/NN
)/)
subsets/NNS
at/IN
different/JJ
stages/NNS
of/IN
myeloid/JJ
commitment/NN
by/IN
reverse-transcriptase/NN
polymerase/NN
chain/NN
reaction/NN
(/(
RT-PCR/NN
)/)
./.
=====
The/DT
highly/RB
specific/JJ
granulomonocyte-associated/JJ
lysosomal/JJ
proteins/NNS
myeloperoxidase/NN
(/(
MPO/NN
)/)
and/CC
lysozyme/NN
(/(
LZ/NN
)/)
,/,
as/RB
well/RB
as/IN
the/DT
transcription/NN
factor/NN
PU.1/NN
,/,
were/VBD
already/RB
detectable/JJ
in/IN
the/DT
most/RBS
immature/JJ
CD34+Thy-1+/JJ
subset/NN
./.
=====
Messenger/NN
RNA/NN
(/(
mRNA/NN
)/)
levels/NNS
for/IN
the/DT
granulocyte-colony/NN
stimulating/NN
factor/NN
(/(
G-CSF/NN
)/)
receptor/NN
,/,
granulocyte-macrophage/JJ
(/(
GM/NN
)/)
-CSF/NN
receptor/NN
alpha/NN
subunit/NN
and/CC
tumor/NN
necrosis/NN
factor/NN
(/(
TNF/NN
)/)
receptors/NNS
I/CD
(/(
p55/NN
)/)
and/CC
II/CD
(/(
p75/NN
)/)
were/VBD
also/RB
detected/VBN
in/IN
this/DT
subset/NN
in/IN
addition/NN
to/TO
c-kit/NN
and/CC
flt-3/NN
,/,
receptors/NNS
known/VBN
to/TO
be/VB
expressed/VBN
on/IN
progenitor/NN
cells/NNS
./.
=====
By/IN
contrast/NN
,/,
the/DT
monocyte-macrophage/JJ
colony/NN
stimulating/NN
factor/NN
(/(
M-CSF/NN
)/)
receptor/NN
was/VBD
largely/RB
absent/JJ
at/IN
this/DT
stage/NN
and/CC
in/IN
the/DT
CD34+Thy-1-CD45RA-/JJ
subsets/NNS
./.
=====
The/DT
M-CSF/NN
receptor/NN
was/VBD
first/RB
detectable/JJ
in/IN
the/DT
myeloid-committed/JJ
CD34+Thy-l-CD45RA+/JJ
subset/NN
./.
=====
All/DT
other/JJ
molecules/NNS
studied/VBN
were/VBD
found/VBN
to/TO
be/VB
expressed/VBN
at/IN
this/DT
stage/NN
of/IN
differentiation/NN
./.
=====
Different/JJ
cocktails/NNS
of/IN
the/DT
identified/VBN
ligands/NNS
were/VBD
added/VBN
to/TO
sorted/VBN
CD34+Thy-1+/JJ
single/JJ
cells/NNS
./.
=====
Low/JJ
proliferative/JJ
capacity/NN
was/VBD
observed/VBN
after/IN
1/CD
week/NN
in/IN
culture/NN
in/IN
the/DT
presence/NN
of/IN
stem/NN
cell/NN
factor/NN
(/(
SCF/NN
)/)
+/JJ
Flt-3/NN
ligand/NN
(/(
FL/NN
)/)
+/JJ
G-CSF/NN
./.
=====
Addition/NN
of/IN
GM-CSF/NN
to/TO
this/DT
basic/JJ
cocktail/NN
consistently/RB
increased/VBD
the/DT
clonogenic/JJ
capacity/NN
of/IN
single/JJ
CD34+Thy-1+/JJ
cells/NNS
,/,
and/CC
this/DT
effect/NN
was/VBD
further/RB
enhanced/VBN
(/(
up/RB
to/TO
72.3/CD
+/-/CC
4.3/CD
%/NN
on/IN
day/NN
7/CD
)/)
by/IN
the/DT
inclusion/NN
of/IN
TNF-alpha/NN
./.
=====
In/IN
conclusion/NN
,/,
the/DT
presence/NN
of/IN
myeloid-associated/JJ
growth/NN
factor/NN
receptor/NN
transcripts/NNS
in/IN
CD34+/JJ
CB/NN
subsets/NNS
does/VBZ
not/RB
discriminate/VB
the/DT
various/JJ
stages/NNS
of/IN
differentiation/NN
,/,
with/IN
the/DT
exception/NN
of/IN
the/DT
M-CSF/NN
receptor/NN
./.
=====
In/IN
addition/NN
,/,
we/PRP
show/VBP
that/IN
TNF-alpha/NN
is/VBZ
a/DT
potent/JJ
costimulatory/JJ
factor/NN
of/IN
the/DT
very/RB
immature/JJ
CD34+Thy-1+/JJ
CB/NN
subset/NN
./.